MA26666A1 - ANTIOXIDE, ANTIPROLIFERATE COMPOSITION, INCLUDING CARNITINE AND CAROTENOIDE. - Google Patents

ANTIOXIDE, ANTIPROLIFERATE COMPOSITION, INCLUDING CARNITINE AND CAROTENOIDE.

Info

Publication number
MA26666A1
MA26666A1 MA25710A MA25710A MA26666A1 MA 26666 A1 MA26666 A1 MA 26666A1 MA 25710 A MA25710 A MA 25710A MA 25710 A MA25710 A MA 25710A MA 26666 A1 MA26666 A1 MA 26666A1
Authority
MA
Morocco
Prior art keywords
antiproliferate
antioxide
carotenoide
composition
including carnitine
Prior art date
Application number
MA25710A
Other languages
French (fr)
Inventor
Cavazza Claudio
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of MA26666A1 publication Critical patent/MA26666A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Cardiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA25710A 1998-08-03 1999-08-03 ANTIOXIDE, ANTIPROLIFERATE COMPOSITION, INCLUDING CARNITINE AND CAROTENOIDE. MA26666A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998RM000516A IT1302125B1 (en) 1998-08-03 1998-08-03 COMPOSITION WITH ANTIOXIDANT AND ANTIPROLIFERATIVE ACTIVITY INCLUDING A CARNITINE AND A CAROTENOID

Publications (1)

Publication Number Publication Date
MA26666A1 true MA26666A1 (en) 2004-12-20

Family

ID=11406082

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25710A MA26666A1 (en) 1998-08-03 1999-08-03 ANTIOXIDE, ANTIPROLIFERATE COMPOSITION, INCLUDING CARNITINE AND CAROTENOIDE.

Country Status (21)

Country Link
EP (1) EP1102584A2 (en)
JP (1) JP2002522382A (en)
KR (1) KR20010072146A (en)
CN (1) CN1311674A (en)
AR (1) AR021172A1 (en)
AU (1) AU5064199A (en)
BR (1) BR9912703A (en)
CA (1) CA2338035A1 (en)
EE (1) EE200100052A (en)
HK (1) HK1039062A1 (en)
HU (1) HUP0102807A2 (en)
IL (1) IL140797A0 (en)
IS (1) IS5816A (en)
IT (1) IT1302125B1 (en)
MA (1) MA26666A1 (en)
NO (1) NO20010532L (en)
PL (1) PL346161A1 (en)
SK (1) SK1252001A3 (en)
TN (1) TNSN99152A1 (en)
TR (1) TR200100333T2 (en)
WO (1) WO2000007581A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1286704T3 (en) 2000-06-02 2014-09-22 Univ Texas Ethylenedicine (EC) -glucose analog conjugates
US6923960B2 (en) 2001-10-03 2005-08-02 Vsl Pharmaceuticals Inc. Antioxidant combination composition and use thereof
KR100523562B1 (en) 2001-10-29 2005-10-25 한국과학기술연구원 Neuroprotective composition comprising an extract from opuntia ficus-indica and compounds isolated therefrom
JP4527938B2 (en) * 2002-07-23 2010-08-18 オルビス株式会社 Orally administered composition for antioxidant
JP4334189B2 (en) * 2002-07-30 2009-09-30 カゴメ株式会社 AGE production inhibitor
ITRM20020620A1 (en) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti USE OF CARNITINE FOR THE PREVENTION AND / OR TREATMENT OF DISORDERS CAUSED BY ANDROPAUSE.
DE602004019508D1 (en) 2003-04-14 2009-04-02 Nippon Soda Co DIAMIDE DERIVATIVE, METHOD OF MANUFACTURE AND ANTIOXIDATION MEDICAMENTS
US9050378B2 (en) 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
KR20060132667A (en) * 2004-01-28 2006-12-21 네스텍소시에테아노님 Nutritional composition for improving skin condition and preventing skin diseases
US8758723B2 (en) 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
RU2619342C1 (en) * 2016-02-24 2017-05-15 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Medication for prevention and treatment of free radical pathology in animals
CN113491687A (en) * 2020-04-02 2021-10-12 常州高新技术产业开发区三维工业技术研究所有限公司 Detoxifying medicine composition and application thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
EP0400547A1 (en) * 1989-06-02 1990-12-05 Abbott Laboratories Parenteral nutrition product
IT1276225B1 (en) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITIONS CONTAINING L-CARNITINE AND ALKANOYL L-CARNITINE IN ASSOCIATION WITH RESVERATROL OR ITS DERIVATIVES USEFUL FOR
IT1277953B1 (en) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITION CONTAINING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND A 3-OMEGA SERIES POLYUNSATURED ACID USEFUL
IT1283967B1 (en) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti USE OF L-CARNITINE OR L-CARNITINE DERIVATIVES AND ANTIOXIDANTS IN THE PREVENTION AND TREATMENT OF PATHOLOGIES ARISING FROM OXIDATIVE DAMAGES
US5667791A (en) * 1996-05-31 1997-09-16 Thione International, Inc. X-ray induced skin damage protective composition
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
IT1291113B1 (en) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti NUTRITIONAL THERAPEUTIC COMPOSITION FOR SUBJECTS WITH DIABETES MELLITUS

Also Published As

Publication number Publication date
AU5064199A (en) 2000-02-28
NO20010532D0 (en) 2001-01-31
KR20010072146A (en) 2001-07-31
EP1102584A2 (en) 2001-05-30
NO20010532L (en) 2001-03-20
JP2002522382A (en) 2002-07-23
WO2000007581A2 (en) 2000-02-17
IL140797A0 (en) 2002-02-10
EE200100052A (en) 2002-06-17
SK1252001A3 (en) 2001-08-06
TNSN99152A1 (en) 2005-11-10
HK1039062A1 (en) 2002-04-12
CA2338035A1 (en) 2000-02-17
AR021172A1 (en) 2002-07-03
ITRM980516A1 (en) 2000-02-03
ITRM980516A0 (en) 1998-08-03
CN1311674A (en) 2001-09-05
IS5816A (en) 2001-01-16
BR9912703A (en) 2001-05-02
TR200100333T2 (en) 2001-07-23
WO2000007581A3 (en) 2000-05-11
IT1302125B1 (en) 2000-07-31
PL346161A1 (en) 2002-01-28
HUP0102807A2 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
CU23049A3 (en) DIHYDROPIRIMIDINS.
ID29241A (en) TERANELASI KINOLIN DISTRICTS-1,2
TR199900531A3 (en) Pirazolopyrimidines and pirazolotriazines.
TR199902372A3 (en) Who sulfanylsilane.
DK1139739T3 (en) Agrochemicals
IT1312540B1 (en) COMPOSED.
IT1309578B1 (en) PIGMENTED PHOTOINDURABLE COMPOSITION.
MA26666A1 (en) ANTIOXIDE, ANTIPROLIFERATE COMPOSITION, INCLUDING CARNITINE AND CAROTENOIDE.
IT1307041B1 (en) PESTICIDE COMPOSITION.
DK1149106T3 (en) 4,5-azolo-oxindoles
ID26368A (en) DECREASED 2, HYDROMICIN DEXY
DE59909590D1 (en) AZIDFREE, GAS-CREATING COMPOSITION
ES1040916Y (en) PERFECTED MICROTERMINAL.
IT1304521B1 (en) CURLER.
ES1039265Y (en) PERFECTED ROCODROMO.
ES1039438Y (en) PERFECTED EXHIBITOR-DISPENSER.
ES1039261Y (en) PERFECTED CASE.
ES1040589Y (en) DISPLAY-DISPENSER.
ES1039730Y (en) RODAPIE.
ES1042117Y (en) TABLE-UMBRELLA.
ES1040633Y (en) ESCALIFONO.
ES1040343Y (en) CARTAITO FREGONA.
ES1040731Y (en) GAFA.
ITBO980260A1 (en) RIAVVOLGICARTA.
ITNA980067A1 (en) BLOCCATAPPO.